There's no underplaying the seriousness of chronic obstructive pulmonary disease (COPD), the third leading cause of death worldwide, but a new study suggests laughter may be the right response.

A diagnosis of pulmonary fibrosis gave Monica Reyes, 50, a new outlook on life and how to help the patients she works with.

A new PLOS Aging and Health opinion article argues that dignity, long celebrated in healthcare ethics but rarely measured, ...

DUBAI,9th October, 2026 (WAM) -- Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has premiered a new short film as part of a campaign to raise awareness of Idiopathic ...

Lupin Limited launched Formoflo-G® MDI, a fixed-dose triple-combination metered-dose inhaler (MDI) for the management of ...

The global respiratory care devices market is valued at USD 25.5 billion in 2026 and is projected to reach USD 36.7 billion by 2031, growing at a CAGR of 7.6% over the forecast period (2026–2031), ...

A new study links SGLT2 inhibitor therapy with reduced circulating activin A, improved right-heart function, and modulation ...

“MOST people do have an idea about what they want - it’s just no one’s ever asked them before. That’s why this service is ...

A single injection of the next-generation drug rademikibart markedly cut the rate and impact of acute exacerbations among ...

A diagnosis of chronic obstructive pulmonary disease (COPD) might bring fear and uncertainty. But Leah Knabe, APRN, a family ...

TOORA resident Sheryl is determined to boost awareness of chronic obstructive pulmonary disease (COPD) and encourage those affected to seek available support. “We need a whole lot more funding so we ...

Among neurocritical patients, older age and COPD are significant risk factors for VAP, according to a systematic review and meta-analysis.